// App-Quantinova.ai

[FRI0411] : A MULTICENTER PROSPECTIVE EVALUATION OF THE RISK PROFILE IN PREGNANT PATIENTS WITH PERSISTENT POSITIVITY FOR ANTIPHOSPHOLIPID ANTIBODIES (APL)

Researchers

Presenter

  • M. Fredi

Principal Investigators

  • E. Aggogeri

  • E. Bettiga

  • J.C. Piette

  • N. Costedoat-Chalumeau

  • A. Tincani

  • L. Andreoli

  • M.G. Lazzaroni

  • V. Le Guern

  • A. Lojacono

  • N. Morel

  • C. Nalli

  • M. Taraborelli

  • S. Zatti

Medical Centers

  • Internal Medicine, APHP PitieSalpetriere, Paris, France

  • Rheumatology and Clinical Immunology Unit, Brescia, Italy

  • Internal Medicine, Hospital Saint-Louis, Paris, France

  • Department of Obstetrics and Gynecology, Spedali Civili and University, Brescia, Italy

Locations

  • France

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Antiphospholipid syndrome

  • Deep vein thrombosis

  • Myocardial infarction

  • Pulmonary embolism

  • Venous thrombosis

  • Thrombocytopenia

  • HELLP syndrome

  • Spontaneous abortion

Biomarkers

  • N/A

Drug/Treatment

  • Aspirin

  • Albyl-E

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved